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Perfusion of rat hind limb with glycerol. Catheters 
are placed into femoral artery and vein. 
The amputated, perfused and replanted leg 71 days 
postoperative 
Histology skin 
Skeletal muscle. Focal muscular atrophy and blood 
vessel proliferation. 
New blood vessels 
Peripheral regenerating nerves 
End-to-side anastomosis of inferior epigastric 
artery and vein to femoral artery and vein. 
Raising the flap including the femoral artery and 
vein. 
The vascular pedicle of the inguinal flap including 
the femoral and epigastric vessels. 
A replanted inguinal flap 2 months postoperatively. 
Illustration of harvesting, cryoprotecting, freezing, 
thawing and replanting flap 
The harvested flap is stretched out and perfused with 
glycerol. Most of the blood has been washed out at 
this stage. 
Resin corrosion cast study of inguinal area without 
raising the skin flap. Note the thickness of the 
vessels. 
Another resin corrosion cast study after the flap 
has been raised. The diameter of the vessels is 
significantly smaller 
Necrotic transplanted flap. 



















The Plastic Surgeon is frequently confronted with the problem of large 
soft tissue defects which cannot be covered by skin grafts or local skin 
flaps. The examples are limb injuries, defects resulting after release 
of burn scar contractures and in tumour surgery. Another problem is 
the situation where skin grafts can cover the defects but where the 
resulting deformity severely affects the quality of life, for instance 
in children who sustained severe facial burns. The possibility of a 
composite reconstruction of such a defect by a one stage readily 
available reproducible method is quite appealing. Even more appealing 
would be some means of obtaining an unlimited supply of donor tissues 
which do not require a surgical assault upon the patient or require 
additional operative time during the reconstructive procedure. A 
composite allograft of skin and subcutaneous tissue transf~rred with 
microvascular anastomosis for vascularisation would meet these criteria 












anastomosis and the persistent immunological problems of allograft 
rejection. 
FREE FLAP ALLOTRANSPLANTATION 
Skin has been the organ most used in studying transplantation immuno-
biology but in nearly all cases it has been used as a free graft. A 
review of the literature revealed only two studies dealing with the 
immunologic properties of skin when transferred as an immediately 
vascularised composite allograft (Salyer 1973, Egerszegi 1984). 
Salyer in 1973 showed that the graft versus host reaction could be 
diminished by pretreatment of the recipient with anti lymphocyte serum 
3 
and of the donor with radiation or anti lymphocyte serum. He concluded 
that passenger leucocytes from the donor play a role in the early 
sensitisation of the host but that the near elimination could only delay 
but not prevent the subsequent graft versus host reaction. Egerszegi 
and Daniel 1984/1986 used Cyclosporin A to reduce the immunogenicity of 
free neuro-vascular flaps and complete hand transplants in baboons. 
Some of these transplants have been successful and at the time of 
publishing, been followed up at 211 days for the flaps and 304 days for 
the hand. Complete skin survival was noted as well as reinnervation. 
However, the side effect of Cyclosporin A such as nephrotoxicity, 
hepatoxicity and malignant lymphomata have to be accepted at present for 
such lifesaving operations like heart or liver transplants but are 
unacceptable in the case of limb or skin transplantation. 
Heck et al 1985, successfully transplanted composite skin grafts 
consisting of previously frozen split thickness allograft which were 
overgrafted after removal of the epidermal layer with auto-epidermal 
cells. No signs of rejection were seen at follow up, up to 12 months 
post-operatively. No immunosuppressive agents have been used. 
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AIMS OF -STUDY 
Based on this idea an experimental study was designed to 
discover whether frozen vascularized skin flaps could be transplanted 
without using immunosuppressive drugs. 
establish a technique of vascularized free flap replantation and 
transplantation 
determine the effect of freezing upon skin. Subcutaneous tissue and 
vessels using cryoprotective agents. 
determine to which extent freezing could reduce the antigenicity of 
skin in combination with autograft of the epidermis. 
The overall question was whether skin flaps could be transplanted 
without using immunosuppressive drugs. 
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HISTORY OF ORGAN TRANSPLANTATION 
The birth of organ transplantation took place in Vienna in 1902. 
Emerich Ullmann reported the first transplantation of dogs' kidneys to 
the neck with the aid of Payr's Cannulas for vessel anastomosis of which 
one allotransplant functioned for five days. In 1912 Alexis Carrell of 
Chicago, transplanted not only kidneys but the spleen, the small 
intestine and the thyroid and also made attempts at heart 
transplantation. In 1912, he received the Nobel Prize in recognition 
of his work on vascular suture and the transplantation of blood vessels 
and organs. In the same year Guthrie, the man who had some years 
earlier in Chicago helped Carrell to perfect the vascular suture 
technique, published his book on blood vessel surgery and its 
application. This world-wide recognition that the technical problems 
could be solved should logically have been a prelude to a more general 
use of organ transplantation but, was in reality an end. The 
experiments had shown that autogenic organs survived after vessel 
anastomosis and were able to function despite denervation and lymphatic 
interruption but they had also shown that an unknown biological factor 
frustrated the technical successes in all cases of allo-
transplantation. In this same year the German surgeon Georg Schone 
published conclusive evidence that this unknown process was an immune 
reaction. In his paper published in the Munchner Medizinische 
Wochenschrift he stated that there is a transplantation immunity arid 
which is different from that which regulates the growth of tumour tissue 
but which determines also the fate of normal tissue. Most scientists 
disregarded this work and it was only thirty years later that Medawar 
finally proved that Schone was correct. 
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In further studies over the next 15 years a few surgeons (notably, 
Sauerbruch's assistant Schmidt) tried to solve the problems of 
transplantation by surgical means only. However Schmidt had to admit 
that after his experiments with parabiosis there was very little hope of 
achieving the success with skin transplants using this means. Bittner 
in 1932 showed that susceptibility to tumour transplants was transmitted 
and that this transmission took place strictly according to Mendelian 
laws. Once the genetic basis was clarified there was one major question 
remaining - by what mechanism does the body cause the rejection of 
tissue of a divergent genetic constitution? Among the many different 
hypotheses advanced and tested at this time, two predominant concepts 
emerged, namely, a primary local toxicity of the transplant and a 
general immunisation against foreign tissue. The second view was 
supported by Gorer's observation that in certain strains of mice after 
tumour transplantation an agglutinin against the donor cells circulated 
in the recipient. But here also in the thinking of research workers 
immunity meant serological immunity and the concept of antibodies was 
inseparably linked with the concept of humeral, serologically defined 
antibodies. Serological tests however, continued to be mostly negative 
in transplantation and therefore the problem remained undecided until 
Medawar began his work. On the basis of precise observations of a skin 
graft recipient he concluded with Gibson in 1942 that time factors, the 
absence of a local cellular reaction under certain conditions and the 
more rapid rejection of secondary transplants could be explained only by 
active immunisation of the recipient. One of the important results of 
these ideas was that the presence or absence of humeral antibodies was 
no longer considered to be the decisive criterion of an immune-mechanism 
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but rather the more rapid rejection of secondary transplants. Finaily, 
thirty years after Schone, the immunological origin of allotransplant 
rejection was clearly and definitely proved. Further experimental work 
continued but was interrupted by World War II. However, in 1952, one of 
the pioneers of clinical kidney transplantation David Hume published his 
first experiences. The development of the artificial kidney which had 
made temporary treatment of renal insufficiency possible made the 
replacement of irreversibly diseased kidneys an urgent problem. 
Although this period therefore saw the first major efforts at kidney 
allotransplantation in man, it remained impossible to combat the immune 
reaction and failure was therefore the logical consequence. In the 
same year however, Baker found that corticosteroids could prolong the 
life of allotransplants but it took many years before the cortico 













transplantation had started. For nearly forty years from 1912 to 1950 
technical work on whole organ transplants had been abandoned and now it 
was taken up again. It was advances in anaesthesia, treatment of 
shock, antibiotics, the use of heparin and later extra corporal 
circulation that stimulated and made possible a new phase of surgical 
activity. Kidney, lung and heart transplants were performed 
experimentally with increased enthusiasm in the following years. In 
1962, renal transplantation in man finally became a reality. Both Kuss 
for the group from Paris and Murray from Boston reported on their first 
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long term surviving allotransplant recipients. To achieve these 
results, total body irradiation was used. This was a very dangerous 
procedure which was abandoned later. 
In the early 1960 1 s three events occured which changed the course of 
clinical transplantation. The first was the development of tissue 
typing and these early methods gave the confidence that close matching 
could eventually be obtained. The second was the development of 
methods for regular dialysis treatment in therapy which could be 
integrated with transplantation and the third and most important was the 
appearance of new potent immunosuppressive drugs. 
Karl Landsteiner in his Nobel Prize lecture of 1931 had suggested a 
search for tissue groups analogous to the blood groups which he had been 
first to describe. P.A. Gorer obtained the first evidence for such a 
system in mice and showed that the system was genetically determined as 
did George Snell in America who first used the term 
"histocompatibility". • 
The hunt for human white cell agglutinins and 
hence the sera which could be used for tissue typing was rewarded when 
Jean Dausset in 1952 identified such antibodies in the serum of multiply 
transfused patients, work for which he shared a Nobel Prize in 1980. In 
1958 J J van Rood and Rose Payne independently detected such antibodies 
in multiparous patients and thereafter increasing numbers of antigens 
were identified by such sera using Paul Terasaki's method of testing. 
Starting in Paris in 1962, these methods were increasingly used to match 
donors and recipients. These methods could also be used to test for 
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preformed antibody in the recipient and thus hyper-acute rejection could 
be avoided. 
The second innovation in the early 60s was the invention of Scribner and 
Quinton of the arterio venous shunt. Their finding that patients with 
chronic renal failure could be kept in surprisingly good health by 
regular dialysis profoundly altered the status of transplantation 
treatment. 
Last and most important was the finding by Schwartz and Dameshek in 1959 
that one of the newly derived anti-mitotic agents, 6-Mercaptopurine, had 
potent effects on immune responses while being less toxic than the drugs 
from which it was derived. Roy Calne in a series of 104 canine renal 
allotransplants came to the conclusion that azathioprine was at least as 
effective but less toxic than 6-Mercaptopurine. In 1963, Starzl added 
steroids to azathioprine therapy a combination which remains the 
standard regimen to this day. 
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HISTORY OF SKIN TRANSPLANTATION 
The technique of replacing skin as a free graft has been known for 
centuries. For example, Sushruta who practised in Northern India almost 
2500 years ago is credited with using skin grafting in the repair of 
noses lost in battle or mutilated for punishment of crimes . However, 
the emphasis that surgeons continued to place on the use of skin flaps 
for repair of such defects emphasised that the healing of free grafts 
was probably unsatisfactory. 
any allografts which might 
This was presumably due to rejection of 
have been utilised or perhaps the use of 
autografts which were too thick to permit satisfactory 
revascularisation. The recruitment of slaves or other persons not in a 
position to object as donors for skin allografts was frequently reported 
(Rogers 1959). The long-term success of these allografts is unclear 
but what must have been the rejection phenomenon certainly received 
various interesting explanations. Reports of the sympathetic nose for 
example, which seemed to die when the person from whom it had been taken 
died, indicated that the expected period of 
donor was about equal to the allograft 
survival of the unfortunate 
rejection time. By the 
beginning of the 19th century, techniques were developed before free 
grafting that finally assured a consistent rate of success. Reverdin in 
1871 is attributed with the initial discovery that split thickness skin 
provided a perfectly satisfactory graft without injuring the donor site. 
Shortly thereafter Thiersch further advanced the knowledge of skin 
grafting with the first histological study of graft healing. As early 
as 1880 sheep skin and soon thereafter, porcine skin had been utilised 
for coverage of burn wounds. However, anti-vivisection law 
significantly discouraged further progress into xenografting until a 
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reintroduction of porcine skin as a temporary dressing by Bromberg in 
1965. 
survival. 
The major disadvantage of xenograft skin is its limited 
The grafts, whether fresh, irradiated, or lyophilized 
usually adhered to 
revascularisation. 
the underlying tissues without evidence of 
Thus the porcine xenograft acts really as a 
temporary biologic dressing whose survival is ended by a process of 
desiccation rather than one of rejection. The first allografts of burn 
wound coverage were performed by Pollock in 1870. He applied his own 
skin and that of a black man next to autografts on a patient's burns. 
Subsequently he observed ulceration and loss of the black man's skin and 
his own but continued survival of the autografts. He thus unknowingly, 
provided a description of the importance of histocompatibility for graft 
survival. A true appreciation of the survival to be anticipated 
following placement of allografts or xenografts did not occur until the 
early 20th century being stimulated by the observations of Schone. His 
work correctly demonstrated that prolonged survival was not to be 
expected although the fundamental dependence of graft survival upon the 
immunogenetic relationship between donor and recipient remained unknown. 
It was not until the early 1940s that the most important monumental work 
of Gibson and Medawar describing skin transplants in man and rabbits 
finally placed the knowledge of the laws of transplantation on a firm 
scientific basis. This work finally provided a solid foundation for 
the subsequent rapid development of cellular immunology and 
immunogenetics. The first observations which were made held till today 
viz. that when skin allografts are exchanged between healthy volunteers 
including closely matched siblings mean graft survival time is usually 
12-16 days. 
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It has become evident however, that patients suffering severe thermal 
injuries especially when their course is complicated by prolonged 
convalescence and 
immune competence. 
malnutrition have major alterations in the 
This is manifested as a non-specific immunological 
deficit which partially accounts for the recurrent and often fatal 
infections they suffer. This altered immune response may be exploited 
to allow prolonged skin allograft survival as has been demonstrated both 
clinically and experimentally (Alexander and Montgrief 1966). 
Randomly selected allografts generally reject during the second or third 
post-transplant week. But it was observed that in the non-septic well 
nourished child even grafts obtained from ABO compatible parents 
survived no more than three weeks (Whelchel et al). Allografts as a 
means of wound coverage, therefore, have also been of limited usefulness 
in treating burns except where used as repeatedly replaced biologic 
dressings. This has been an effective approach for patients suffering 
moderate-sized burns which then can be fairly rapidly closed with 
autogr aft skin from uninjured donor sites. In the more massively 
injured patient however, this approach with its hazards of repeated 
anaesthetic exposures, blood and fluid losses and recurrent infections 
has been almost universally unsuccessful. Immunosuppressive agents 
have been used to prolong skin allograft survival until the wounds which 
were primarily and continuously closed with allografts could gradually 
resurface with sequentially harvested autografts. Today temporary 
allografts are the basis of salvaging massively burned patients. The 
small amount of useable autograft is intermingled with allografts. 
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ANTIBODY STRUCTURE AND FUNCTION 
. 
The injection or introduction of a foreign tissue into an animal or a 
human such as by .transplantation can elicit the ability to react against 
that specific foreign substance. Immunologists term the foreign 
invader an immunogen or antigen with the protein formed against it being 
known as an immunoglobulin or antibody. 
biologic properties including the following. 
Antibodies have various 
(1) The ability to bind specifically with antigen. 
(2) The ability to fix (bind) and thus activate serum complements -
these are a series of proteases that, once activated, can mediate 
lysis of cells and 
(3) The ability to enhance phagocytosis by a process known as 
opsonization. In opsonization, immunoglobulin first binds with 
antigen and then subsequently attaches to a phagocytic cell. 
(Hutchinson et al 1977) The foreign particle remains bound to one 
end of the immunoglobulin molecule so that the phagocyte can then 
ingest the foreign material and destroy it. 
Five different classes of immunoglobulin molecule exist. These are IGG 
IGM IGA IGD and IGE. 
Cellular interactions in the immune response. 
Lymphocytes 
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Lymphocytes become activated upon binding a specific antigen to a 
receptor on the cell surface. If the lymphocyte is a B-cell (bone 
marrow derived lymphocyte) then differentiation will occur 
antigen binding. The receptor on the B-cell consists 
following 
of an 
immunoglobulin that is specific to a particular antigen. The B-cell 
then ultimately becomes a plasma cell which produces and secretes 
immunoglobulin molecules (Janeway and Jason 1980). T-cells (thymus-
derived lymphocytes) participate in the immune response by modulatory 
and effector functions. The receptor for specific antigen on T-cells 
appears different from the immunoglobulin receptor presente on the 
surface of B-cells. Yet, it seems that the antigen binding sites of 
both types of receptors function similarly (Achauer 1985). 
T-cells include the following: 
those with modulatory functions 
Helper T-cells which amplify the immune response 
Suppressor T-cells which inhibit the immune response 
These regulate both effector T-cells and B-cells (Steinmuller 1978). 
Killer T-cells (cytotoxic T-cells) mediate target cell destruction. 
Macrophages 
Activation of helper T-cells (amplifier T-cells) requires the synthesis 
of a soluble factor termed Interleukin-1 by macrophages. This occurs 
either simultaneously or following the presentation of antigen to the T-
cell by the macrophage. Thus macrophages also participate in the 
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Interleukin 2 is then produced by T- amplifier cells concomitantly wi th 
the synthesis for receptors of Interleukin-2 on the surface of these 
cells. Full activation of T-amplifier cells can then proceed as a 
result of production of Interleukin 2 (Bunjes et al 1981). Activated 
lymphocytes can produce other soluble mediators which can activate 
macrophages to become more phagocytic with enhanced bactericidal 
effects. Soluble factors produced by lymphocytes are collectively 
termed lymphokines (Guttmann 1981). 
Major histocompatibility complex 
A great deal has been written on this subject, but the following short 
summary of its role in transplantation biology suffices for this 
dissertation. 
The major histocompatibility gene complex is known as the HLA complex in 
humans and is located on Chromosome 6. The major histocompatibility 
gene complex in the mouse is termed the H2 complex. In the mouse it 
has been shown that cell interaction genes located in the H2 complex 
regulate T-cell, B-cell and macrophage interactions. Immune response 
genes also located in the H2 complex regulate the ability of an 
individual to respond against antigenic challenge. 
antigens are major histo-compatibility complex 
participate in inducing allogenic immune responses. 
Transplantation 
gene products and 
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IMMUNOSUPPRESSION IN TRANSPLANTATION 
A. Non-specific Immunosuppression 
The immune system of an individual can be readily depressed by a large 
all the number of drugs and other agents. The disadvantage of 
immunosuppressive agents however, has been the non-specific way in which 
they act in an environment teeming with potentially pathogenic micro-
organisms. Man requires his immune system as a defence and any 
impairment of that function will necessarily increase his susceptibility 
to infection. Fortunately it is often possible with conventional drugs 
to reach a half-way situation where rejection is suppressed yet the 
patient's ability to fight infection still retained. Just how this is 
accomplished at an immunological level is not well understood., for the 
interaction of drugs on the various mediators of the immune response is 
extremely complex (Berenbaum 1974). It would seem that under an 
umbrella of non-specific immunosuppression the immune system becomes 
adapted to accept the transplant thereby allowing the doses of drugs to 
be reduced. Such adaptation is essential since without it, high doses 
of drugs or other agents would be required indefinitely and their severe 
toxic effects would be inevitable. Although some form of adaptation 
undoubtedly occurs in successfully transplanted patients, drug therapy 
even at very low doses is still required. 
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Pharmacological immunosuppressive agents 
Transplant rejection starts with the recognition of foreign material by 
the immune system and it is thought that macrophages have an important 
role in this step. Agents that immobilise macrophages such as gold, 
silica and anti-macrophage serum can help to prolong the survival of 
tissue allografts. Soon other members of the lymphoid system are 
involved with proliferation of those cells with specificities of the 
foreign antigens. B-cells develop into plasma cells, and K-cells and 
macrophages invade the graft to bring about its destruction. It is 
because cell proliferation forms part of the immune response that many 
cytotoxic drugs are immunosuppressive. The action of these drugs is 
better understood if one considers the metabolic events that occur in 
cell division. 
The cell cycle 
Lymphoid cells like other cells in the body replicate by cell division. 
THE CE LL C. Y C LE 
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The metabolism of such cells enters a cycle which comprises the Gl (gap 
phase 1) (the state at interphase), passes through a DNA synthesising or 
S phase to premitotic resting phase G2. Then follows the Mor mitotic 
phase, and the cell once again enters interphase. In a non-stimulated 
lymphocyte population many of the cells are not in cycle but in a 
prolonged Glor GO. Some immunosuppressive drugs are phase specific 
in that they only act during certain parts of the cycle. Anti-
metabolites which include azathioprine are active during the S-phase and 
consequently are only effective against dividing cells. Alkylating 
agents act at many points of the cycle and some agents such as nitrogen 
mustard, cyclophosphamide and irradiation are also effective against 
resting GO cells.(Hill and Baserga 1975) 
Anti-inflammatory effects of immunosuppressive drugs 
The immune process that brings about rejection of a foreign tissue is 
usually accompanied by a local inflammatory response. Lymphocytes, 
macrophages and polymorphs are attracted to the area in a non-specific 
way. Therefore drugs which act as anti-inflammatory agents will also 
depress to some extent the expression of an immune response without 
necessarily modifying the specific 
underlies it. 
lymphocyte sensitisation which 
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Anticoagulants and rejection 
Fibrin deposition and thrombosis and small arteries are common features 
of rejection especially when there is antibody mediated damage. 
Unfortunately anticoagulants have not been very helpful in preventing 
this. 
Immunosuppressive compounds 
A vast range of different compounds seem capable of depressing the 
immune response but it has been particularly disappointing that so few 
of these have shown potential as immunosuppressive agents in man. 
Anti-metabolites 
These compounds interfere with protein synthesis by competing for and 
blocking specific receptors. They include the purine antagonist 6-
mercaptopurine and azathioprine, the pyrimidine antagonist 5 fluoro-
uracil and the folic acid antagonist methotrexate. 
Since these agents are cycle-specific and only effective against 
proliferating cells they are most effective when given after, rather 
than before the exposure to antigen. Goldwyn et al studied the 
feasibility of canine limb homotransplantation using 6-Mercaptopurine 
and azathioprine as immunosuppressive drugs. In the untreated group by 
the sixth post-operative day the limb transplant showed active tissue 
destruction and started to lose its viability. Survival could be 
prolonged to a mean of 18 days by the administration of azathioprine. 
Thus the immunosuppressive therapy only postponed the rejection process 
but did not significantly alter its outcome. 
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Alkylating agents 
These compounds possess an alkyl radical with active terminal end groups 
which can bind two or more different molecules causing them to become 
cross-linked. The alkylating agents are mostly cycle-specific but 
their activity is in general not confined to just one phase. Some 
agents such as Nitrogen mustard, Sulphurmustard and Cyclophosphamide are 
also active against resting cells. With most alkylating agents DNA 
synthesis is inhibited to a greater extent than is RNA synthesis but the 
alkylation of DNA does not necessarily lead to cell death since repair 
is possible. Although alkylating agents have been useful in treating 
malignancies they have 
irnrnunosuppressants. 
on the whole been of little value as 
Steroids 
In organ transplantations steroids are frequently administered in high 
concentrations as a prophylaxis against rejection or for treatment of 
rejection after it has occurred. The side effects of such treatment are 
well known and it is surprising that the dosage is still largely 
empirical with different kidney 
contrasting regimes (McGeown, 1973). 
actions at the biochemical level. 
transplant centres using very 
Steroids have a large number of 
They bind to specific cytoplasmic 
receptors which transport them to intranuclear receptors where, at toxic 
levels they inhibit a variety of enzymes, with a resulting depression of 
protein, RNA and DNA synthesis. There is extensive death of small 
lymphocytes both in the blood and in the thymus, lymphnodes and spleen 
although the mechanism for this last effect is not well understood. It 
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is often assumed that high dose steroid therapy must be started 
immediately rejection has been diagnosed if the graft is to be saved and 
yet this may not be true. Salaman and Couhig (1980) found, using a rat 
heart allograft model that a single pulse of methylprednisolone 
is more effective in prolonging graft survival whe~ given late than when 
given early in the rejection process. In organ transplantation it has 
been the usual practice to administer high doses of steroids immediately 
after transplantation as a prophylaxis against rejection.(Salaman 1982) 
The complications of such treatment have led to the realisation that 
heavy steroid dosage during the first month following transplantation is 
probably not required. Studies in England (Chan et al 1980, Kauffman 
et al 1977) showed that patients on low dose therapy with 25mg 
prednisolone daily showed even better results with less complications 
than those treated with high doses (150mg for three days that was 
reduced to 30 mg over the following three weeks). Steroids seem to be 
the only agent which can reliably reverse rejection episodes.(Chan et al 
1980) It is usual practice to treat a rejection episode with high 
doses of steroids for 3 to 5 days after which the graft will often 
recover. (Bell et al, 1973; Salaman & Couhig, 1980) The treatment is 
repeated if there has been no response but most transplant centres would 
not treat for a third time since the patient would be very likely to 
develop complications which might prove fatal.(Mussche et al, 1976; Gray 
et al, 1978; McGeown et al, 1977) 
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Complications of non-specific Immune suppression. 
The administration of azathioprine and prednisolone can be associated 
with a great variety of toxic effects. 
(i) Infections - New or reactivation of latent, for instance TB. 
(ii) Impaired growth and wound healing 
(iii) Bone disease osteoporosis, avascular necrosis, marrow 
suppression 
( iv) Cataracts and other ophthalmic complications 
(v) Diabetes, obesity, cushingoid appearance 
(vi) Peptic ulceration, colonic perforations 
(vii) Pancreatitis, liver dysfunction 
(viii) Hypertension 
(ix) Psychiatric disturbances 
(x) Malignancy 
Infection is the greatest threat to the patient and many transplant 
centres adopt a policy of barrier nursing their patients during the 
first few weeks after transplantation. A few years ago patients were 
at great risk of dying from bizarre fungal and viral infections but with 
a more cautious use of immunosuppression nowadays these life-threatening 
infections are seen much less often.(U.K. Transplant Service 1980) Of 
the other non-fatal complications 







appears to afflict patients quite randomly and has been unrelated to the 
total dose of steroid administered.(Salaman 1982) Some form of 
prophylaxis is available against the more serious side effects. 
Continuous medication with antacids and/or cimetidine should prevent 
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Complications of immunosuppression. 
The administration of azathioprine and prednisolone can b 
with a great variety of toxic effects. 
(i) Infections - New or reactivation of 
(ii) Impaired growth and wound healing 
(iii) Bone disease 
suppression 
osteoporosis, avascular 
(iv) Cataracts and other ophthalmic compli 
(v) Diabetes, obesity, 
(vi) Peptic ulceration, 








Infection is the greatest 
centres adopt a policy 
first few weeks after 
the patient and many transplant 
nursing their patients during the 
A few years ago patients were 
at great risk of dyin from bizarre fungal and viral infections but with 
immunosuppression nowadays these life-threatening 
infections much less often.(U.K. Transplant Service 1980) Of 
the other complications perhaps the most disabling is 
which usually affects the femoral head. This 
appears to patients quite randomly and has been unrelated to the 
steroid administered.(Salaman 1982) Some form of 
is available against the more serious side effects. 
with antacids and/or cimetidine should prevent 
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ulceration and long term anti- tuberculose therapy may be needed for 
patients who have contracted this disease in the past. 
Blood transfusion effects and immunological enhancement 
In 1973 Opelz et al demonstrated that the success of cadaver renal 
transplants one year following surgery has significantly improved in 
patients, who had received nonspecific random blood transfusions prior 
to transplantation, compared with non-transfused patients. In a more 
recent study these investigators reported a strong dose effect of prior 
blood transfusion on kidney allograft survival (Opelz et al 1981). Many 
other reports have supported the beneficial effect of blood transfusions 
on human renal allograft survival (Solheim 1979, Persijn et al 1977, 
Williams et al 1979). 
The beneficial effect of previous administration of blood has also been 
demonstrated in animal studies. Skin allograft survival has been 
enhanced in minimally immunosuppressed mice by pretransplant 
administration of donor strain white blood cells (Wood et al, 1981) or 
multiple non-specific blood transfusions (Okazaki et al 1980). 
The mechanisms underlying immunologic enhancement remains unclear. 
Several possibilities have been advanced. 
1. Induction of enhancing antibody, which has been theorized to 
interfere with antigen recognition (Morris 1971; Snell et al 1960). 
2. Opsonization of antigen-reactive cells by antigen-antibody 
complexes which may serve to inhibit host cellular migration to 
graft tissue (Hutchinson 1977). 
24 
3. Induction of anti-idiotypic antibodies, which would block 
lymphocytic proliferative responses through the bindings of 
receptor idiotypes (Binz & Wigzell 1975). 
4. Loss of donor passenger leukocytes carried in donor allogenic 
been demonstrated to be tissue (Billingham, 1971) which have 
powerful immunogens (Steinmuller 1967). 
Induction of suppressor T-lymphocytes 
developing alloimmune respor.ses (Dorsch & 
5. which would inhibit 
Roser 1977; Rilshaer & 
Brent 1977; Steinmuller 1978). 
6. Inactivation of T-helper lymphocytes in the continued presence of 
major histoincompatible antigens which has been speculated to 
induce specific immune non-responsiveness (Batchelor 1978, 1979). 
Cyclosporin A 
The Cyclosporins A and C were initially isolated from the fermentation 
broth of a cell fungus Tricodermapolysporum (Borel et al 1976). Various 
other cyclosporins have now been identified but only cyclosporins A, C 
and G show strong immunosuppressive activity. Cyclosporin A has been 
markedly effective as an immunosuppressant in a variety of species and 
in the rabbit prolonged survival of kidney allografts has been observed 
after relatively short periods of treatment (Green and Allison 1978). 
This led the authors to suggest that cyclosporin A had helped to induce 
a state of specific immunological tolerance. It is now known that 
although Cyclosporin is particularly effective in the rabbit, the 
mechanism of its action is non-specific. In rats and mice Cyclosporin 
A will readily prolong the survival of skin and heart allografts but its 
action does not persist in these animals and rejection has occured 
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within a short time of stopping treatment. (White 1980, Ki m et al 1984, 
Black et al 1985) It was found unexpectedly when Cyclosporin first 
came to be used in man that the drug was nephrotoxic and some of the 
patients with kidney transplants had prolonged periods of unexplained 
oliguria (Calne et al 1978). This is discussed further later. It was 
also found that a combination of Cyclosporin A, Prednisolone and a 
Cyclophosphamide analogue was dangerous and was associated with serious 
infections (Calne 1981). The current practice in Cambridge is to treat 
all transplanted patients who have immediately functioning kidneys with 
Cyclosporin A alone but to add short courses of steroids when rejection 
is diagnosed (Calne et al 1981). This treatment was also given to 
patients receiving liver and pancreas transplants with good results 
(Calne et al 1981). Most patients were commenced on a dose of 17 mg per 
kg. of Cyclosporin A per day reduced by 2mg per kg. each month to 6-
8mg/kg per day. The Minnesota/Pittsburgh and Houston groups use 
moderate doses of steroids during induction therapy with a lower 
incidence of allograft rejection (17-30%) opposed to the English groups 
(62-70%). Interestingly only those centres that have noted a lower 
incidence of rejection have reported the benefit in Cyclosporin treated 
transplant patients of a lower risk of infection compared with 
conventionally treated allograft recipients. Long term follow-up for 
steroid complications will indicate which strategy using steroid during 
induction of immunosuppressives or steroid intervention for treatment of 
rejection will be the best to gain the benefit from Cyclosporin 
treatment. 
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Toxicity of Cyclosporin 
The major concern regarding Cyclosporin therapy has focussed upon its 
nephrotoxic and hepatotoxic side effects. At Stanford, in two of 
seventeen cardiac transplant patients an end stage renal disease 
occurred. The biopsies revealed interstitial fibrosis and focal 
sclerosis of glomeruli in many of these patients (Myers et al 1984). 
Similar reports were published in patients with bone marrow transplants 
treated with Cyclosporin (Shulman et al 1981). Rare incidences of a 
haemolytic uraemic like picture have been reported with the use of 
Cyclosporin in renal transplant recipients (van Buren et al 1984). 
Clinical evidence suggests that much of the nephrotoxicity is reversible 
(Salvatierra et al 1983). Significant decreases in serum creatinine 
levels following elective changing of Cyclosporin treated patients to 
azathioprine therapy have been found but the incidence of rejection is 
increasingly high following conversion (19-707.) (Rocher et al 1984). 
At Houston 50 of the 380 renal transplant patients have demonstrated 
intractable nephrotoxicity. Those patients were give azathioprine, 
prednisone and low dose cyclosporin (2-4mg/kg per day) with good 
results. Hepatotoxicity appears to be less of a problem in 
Cyclosporin treated patients. The incidence ranges from 20-407. with 
hyper-bilirubinaemia being the primary pertubation. Most cases can be 
successfully managed by reduction of cyclosporin doses (Flechner et al 
1985). Other side effects are hypertrichosis, fluid retention, 
hypertension and gingival hypertrophy.(Laupacis 1983) 
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Antilymphocyte globulin 
The immunosuppressive property of anti-lymphocyte serum lies in its 
gammaglobulin and it is the gammaglobulin that is usually administerd to 
patients. It was first shown by Woodruff and Anderson in 1963 that ALG 
was an inhibitor of graft rejection (skin homografts in rats). It is 
prepared from the serum of animals that has been immunised with lymphoid 
tissue from another species. In experimental procedures it has been 
shown to have a profound suppressive effect upon cellular immunity and 
to prolong survival of allografts and even xenografts. It probably 
works by severely depleting both the circulating T-lymphocytes and those 
within the lymphoid organs. The problem with ALG is that it is a 
biological product and its potency can vary enormously depending upon 
the type of animal used, the type of antigen injected, the route of 
administration, the purification of the globulin and the mode of 
administration to the patient. The most effective ALG has been raised 
in rabbits that have been injected with human lymphoid cells which have 
been grown in culture or obtained from the thoracic duct or thymus. It 
should be given IV at a high dosage for at least two weeks starting on 
the day of transplantation or the day before.(Thomas et al 1977) It is 
an expensive procedure as is the whole process of ALG manufacture and 
purification.fThomas et al) Nonetheless, a few commercially 
manufactured preparations of ALG are available and some centres use 
these routinely as part of their prophylactic anti-rejection treatment. 
Although active ALG preparations are capable of suppressing rejection, 
the effect may cease as soon as the ALG treatment is stopped. ALG has 
earned a place for itself in the management of rejection 
episodes.(Wechter et al 1979) In patients who have failed to respond 
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to a course of steroids it may be used successfully as a second line of 
treatment without subjecting the patients to hazards of heavy steroid 
therapy.(Shield et al 1979, Light et al 1981) 
Irradiation 
Whole body irradiation was one of the first forms of immunosuppression 
used in human recipients of kidney transplants. Although it was not 
particularly effective and caused considerable morbidity as well as 
mortality a few patients survived with well-functioning transplants 
(Hamburger et al 1962). Much more commonly radiation has been used to 
treat the transplant itself principally at the times of rejection. 
Woolf et al in 1969 showed that irradiation of a dog kidney allograft 
would delay its rejection. Godfrey and Salaman (1977) however, 
performed a controlled clinical trial of 600 rad of graft irradiation to 
patients whose cadaver renal transplants were undergoing rejection. 
They saw no benefit from irradiation, in fact the irradiated group went 
on to have more rejection episodes subsequently. 
irradiation has been found to be more successful. 
Total lymphoid 
Here the supra and 
sub-diaphragmatic fields are irradiated simultaneously and all the major 
lymphnodes, the spleen and the thymus are involved. Slavin et al 
1976,1977 gave 200 rad in 17 fractions to mice which caused a profound 
fall in the level of circulating lymphocytes and although numbers of B-
lymphocytes began to rise after two weeks, the T-lymphocytes remained 
undetectable for at least a month and were still at a reduced level a 
year later. Lymphocytes from these animals responded poorly if at all 
to mitogens or allogenic cells and antibody production was severely 
depressed. Skin allografts survived on these animals for about 50 
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days. A more lasting tolerance has been seen when TLI has been 
followed by an injection of donor bone marrow. When mice were treated 
this way approximately half accepted allogenic skin grafts for more than 
100 days.(Slavin et al 1978) Similar results were obtained in dogs, 
monkeys and baboons.(Slavin et al 1978, 1979) A few transplant centres 
have begun to use TLI for preparing certain patients for kidney 
transplantations and the early results appear to be promising.(Najarian 
1981) It may have a place as a form of pre-treatment for patients who 
have demonstrated strong immunity to previous kidney transplants or 
blood transfusions 
Specific immunosuppression 
Specific immunosuppression may be defined as treatment which directly or 
indirectly selectively suppresses the action of the lymphocyte clones 
responsible for the rejection of the particular graft the patient 
receives i.e. it is antigen specific immunosuppression directed at the 
histocompatibility antigens of the graft donor.(Fabre 1982) One of the 
most important advantages of specific immunosuppression is its safety. 
It is free from the immunological complications of generalised 
immunosuppression (the development of infection and malignancy) and free 
also from non-immunological complications such as the bone marrow 
depression seen with azathioprine. Although the long term aim is that 
specific immunosuppression be used alone for the prevention of graft 
rejection this ideal seems unlikely to be realised in the immediate 
future. To date two major approaches to donor specific 
immunosuppression have been studied. 
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(i) Antigen induced suppression (active enhancement) which refers to 
specific immunosuppression induced by treatment of the recipient 
with preparations containing donor histocompatibility 
antigens.(Billingham et al 1963; Fabre 1976; Little et al 1975; 
Winearls et al 1979) 
(ii) Antibody induced suppression (passive enhancement) where specific 
immunosuppression is induced by the administration to the 
recipient of antibodies directed against donor histocompatibility 
antigens.(Batchelor & Welsh 1976; Gallico et al 1979) Active 
enhancement offers the best hope for the use 
immunosuppression. However, until the factors 
of specific 
are better 
understood, which determine whether exposure to antigen results on 
the one hand in sensitisation or on the other in specific 
suppression active enhancement remains too dangerous for clinical 
use. Passive enhancement has not found any clinical application 
to date as the stimulus necessary for clinical trials has been 
lacking. Other methods being investigated are T-lymphocytes 
suppressor factors (Kohler & Milstein 1975), induction of anti-
idiotypic immunity (Weinberger et al 1980), and antigen suicide 
experiments.(Myburgh & Smith 1973; Weinberger et al 1979) There is 
no currently studied approach likely to be of clinical value in the 
near future but a new and more thorough knowledge of basic 
immunology accummulated in recent years is opening up new avenues. 
Immunosuppression in skin transplantation 
The strong antigenic properties of the epidermis make ~kin graft 
prolongation a particularly exacting test of immunosuppressive agents. 
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The cortico-steroids which have been so effective with azathioprine in 
reducing rejections of renal and cardiac transplantation have had only 
limited success in skin graft recipients. When administered in 
conventional dosages they have not provided significant prolongation of 
skin allograft survival. Azazthioprine also has limited effect.(Burke 
1975) More specific immunosuppression can be achieved with anti-
thymocyte globulin which is also an attractive choice as an 
immunosuppressant for infection prone patients.(Diethelm et al 1974) 
The rather selective T-cell depletion which it produces can be readily 
monitored by the sheep red blood cell rosetting technique.(Bishop et al 
1975) Using this assay the recipient's remaining level of T-lymphocytes 
can be sequentially monitored in order to estimate the degree of 
immunosuppression being achieved and thus subsequent therapy can be 
adjusted appropriately. 
Clinical trials of patients with massive burns who have been treated 
with allografted skin and temporary immunosuppression with cyclosporin 
have shown encouraging results. (Achauer et al 1985, 1986). With low 
dose cyclosporin A (less than one half of the initial dose used for an 
organ transplant) and no concomitant steroids, rapid primary coverage 
with autografts and allografts was achieved. Once the patient had 
healed and suitable donor sites were available, the allografts were 
replaced with autografts and the cyclosporin discontinued. 
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THE EFFECTS OF FREEZING ON TISSUES 
In proposing the hypothesis that freezing alters the antigenicity of the 
transplanted skin (Reels et al 1982; Heck et al 1985; Pegg & Taylor 
1984), it is of importance to note the effects of cooling and freezing 
on the membrane structure. 
Cell membrane structure 
Cell membranes are complex heterogenous structures predominantly 
composed of glycerol phosphatides, cholesterol and proteins. The 
phospholipids are arranged in bi-layers with the polar groups at the 
surfaces whereas cholesterol and proteins are randomly distributed. At 
normal physiological temperatures the phospholipids are highly fluid and 
because of the regular bi-layer arrangement this state is known as 
liquid crystalline. 
Effects of cooling on cell membrane structure 
When it is cooled the lipid bi-layer undergoes a phase change to the gel 
state in which phospholipids are arranged 
lattice and fluidity is vastly reduced. 
occurs at an abrupt transition temperature, 
in an hexagonal crystalline 
The phase change usually 
the value of which varies 
widely with the chemical nature of the lipid. Natural membranes contain 
a complex mixture of many phospholipids with different individual 
thermotropic properties: in these circumstances phase separations occur-
that is, different phases exist simultaneously in the plane of the 
membrane. Cholesterol has the property of reducing membrane fluidity 
above the transition temperature but it inhibits crystallisation and 
therefore increases fluidity below the transition temperature. 
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Intrinsic membrane proteins also affect the thermo-tropic behaviour of 
membrane lipids in a manner similar to cholesterol and produce packing 
faults radiating outwards from the inserted protein. However, the phase 
behaviour of the phospholipids also has a marked effect on protein 
distribution and function. Lateral phase separations occur at low 
temperatures producing regions of phospholipid crystals and regions of 
high protein concentration. Quinn in 1985 proposed a sequence of 
events in which those lipids with the greatest tendency to crystallise 
as hexagonal structures also have the highest transition temperatures. 
During cooling these lipids phase-separate first, producing gel phase 
domains that exclude intrinsic membrane proteins. On rewarming, it is 
proposed that these domains form inverted micelles sandwiched between 
the lipid bi-layer, thereby destroying the barrier properties of the 
membrane. Quinn has made the prediction that hydrophilic neutral 
solutes such as glycerol and Dimethylsulphoxide will reduce the 
transition temperatures of those lipids that tend to separate first 
during cooling and raise the transition temperature of those that 
normally separate at lower temperatures. This would reduce the 
segregation of protein from lipid and prevent the formation of inverted 
micelles. One additional mechanism of membrane damage that is well 
established involves oxygen free radicals. These highly toxic agents 
are generated by the step-wise addition of the four electrons that are 
normally added to oxygen in a single step by cytochrome aa3. The 
enzymes superoxide dismutase (SOD), catalase (CAT) and glutathione 
peroxidase are normally responsible for converting these radicals to 
harmless water and many compounds including mannitol, glycerol and 
dimethylsulphoxide for example, have free radical scavenging properties. 
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Free radicals attack membrane lipids releasing lipid peroxides and 
seriously damaging the cells. Since free radical reactions have a low 
activation energy they are depressed to a lesser extent by decreasing 
temperatures than the enzymatic reactions that normally remove them and 
it is therefore entirely possible that oxygen free radicals are 
important in hypoth~rmic injury.(Stuart et al 1985) 
Effects of freezing 
By further lowering the temperature the chemical reactions are not 
merely retarding but arresting with the probability that lower 
temperature membrane damage will be increased. Hbwever, the major 
difficulties are due to the formation of ice and effective 
cryopreservation requires means of preventing freezing injury. 
Mechanism of freezing injury 
When aqueous solutions freeze, only sufficient ice is formed at each 
temperature to concentrate the solutes in the remaining liquid in order 
to produce a solution with that freezing point. The question therefore 
arises: "are cells damaged by the fall in temperature, the ice, or the 
increase in solute concentration?" 
Effects of increasing salt 
The studies of Lovelock (1953) showed that the injury to erythrocytes 
that was produced by slow cooling to relatively high sub-zero 
temperatures could be accounted for quantitively by the increase in salt 
concentration in the remaining liquid phase. He showed that cells 
exposed to high salt concentrations whether by freezing or by direct 
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exposure to strong salt solutions without freezing were made susceptible 
to damage by further cooling or by returning them to an isotonic 
environment (osmotic shock). These changes were attributed to damage by 
high electrolyte concentrations to the cell membranes. This mechanism 
has been termed solution effects and is dominant at low cooling rates. 
As the cooling rate is increased cell recovery first increases, then 
reaches a maximum and then decreases. The rate giving maximum recovery 
varies from cell to cell so the meaning of slow cooling in this context 
also varies from cell to cell. This characteristic response to cooling 
rate has been explained as the consequence of two distinct damaging 
mechanisms that are oppositely dependent on cooling rate. Solution 
effects are presumed to be both time and temperature dependent and 
therefore to be reduced by increasing the cooling rate thus producing an 
increase of survival with more rapid cooling. Mazur in 1977 showed 
that the fall in cell survival after still more rapid cooling is due to 
the occurence of intracellular freezing. The dependence of 
intracellular freezing on the cooling rate rises because the cell 
contents have a greater tendency to super cool than the external fluid. 
Hence, ice forms first in the extracellular space and the consequent 
rise in solute concentration produces an osmotic pressure gradient 
across the cell membrane. If cooling is sufficiently slow, 
equilibrium will be maintained by the loss of cell water and ice will 
never form intracellularly. However, as the rate of cooling is 
increased, water will eventually be unable to leave the cells fast 
enough to maintain equilibrium. An intracellular freezing will be 
progressively more likely. Mazur has examined and analysed these 
phenomena extensively. He has shown that the critical cooling rate for 
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intracellular freezing differs widely from cell to cell and is primarily-
dependent on two parameters. These are the water permeability of the 
cell membrane and the surface area to volume ratio of the cell such that 
optimal cooling rates for red cells, Hela cells and mouse-ova as 
C per minute examples are approximately 3000, 50 and 10 
respectively.(Mazur 1977) The fundamental mechanisms of cell damage by 
solution effects and intracellular freezing are still a matter of 
debate. Intracellular freezing is generally supposed to damage by a 
directly destructive effect of the ice crystals upon intracellular 
structures although other mechanisms have also been proposed. Whatever 
the fundamental mechanism, it is at least clearly established that there 
is an optimum cooling rate for each cell type, that these optimum rates 
vary very widely and that the peak recovery and that optimum also vary 
from negligible to almost 1007. with different cells. 
Properties and effects of cryoprotectant agents (CPA) 
Cryoprotectant compounds are able to increase the absolute survival at 
the optimum cooling rate but they also change the optimum cooling rate 
(Pegg 1984). On the basis of his electrolyte theory of freezing 
injury, Lovelock (1954) proppsed, that the addition of any compound that 
has a high solubility, a low molecular weight, and will permeate cells 
without toxicity, will reduce freezing injury. Compounds that need 
these requirements are cryoprotectant, the best known being glycerol and 
dimethylsulphoxide. The additon of these compounds simply increases the 
total concentration of solutes and therefore reduces the amount of ice 
formed at any sub-zero temperature and hence limits the rise in salt 
concentration. For this to be effective, high molar concentrations of 
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the added solute are needed (1-5 molar) and this is the reason for 
requiring high solubility and low molecular weight. 
The ideal cryoprotective agent should penetrate rapidly and uniformly 
into cells without undue osmotic stresses, should control the size and 
rate of ice crystal formation by binding intracellular water, and should 
be non-toxic. Glycerol has little toxicity but penetrates slowly, while 
dimethylsulphoxide penetrates rapidly, but is nephrotoxic. High 
concentrations of the agents are needed for adequate cryoprotection but 
the concentrations required are usually associated with severe organ 
toxicity and severe vascular damage. (Marshall 1982) 
Cryoprotectants must be non-toxic but every compound is harmful if its 
concentration is raised sufficiently. There is always an optimal initial 
concentration for cryopreservation which is a compromise between 
cryopreservation and toxic action. It is commonly in the range of 1- 2 
molar with glycerol or dimethylsulphoxide but the precise nature of 
toxicity at higher concentrations is unclear. Since most cryoprotectants 
do penetrate the cells, osmotic lysis occurs if the external medium is 
diluted too rapidly and the so-called toxic limit is therefore very 
sensitive to the means used to remove the cryoprotectant. The 
interactions of temperature, liquid volume, salt concentration and 
cryoprotectant concentration 
understood at the present time. 
are complex and only incompletely 
Not only does the cooling rate and the 
cryoprotective agent concentration interact in determining cell survival 
but also the warming rate and cooling rate interact in determining cell 
survival. Akhtar et al in 1979 could show that cooling L-cells at 1° 
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per minute was associated with an optimal warming rate of 200°C per 
minute but the same recovery could be obtained by cooling at 0.2° per 
minute and warming at 0.3°c per minute. 
The changes with rewarming 
The rate of rewarming has several fundamental effects on phenomena 
occuring in and around the cells at low temperatures. If cooling has 
been too rapid for all the ice to form extracellularly there will be 
small intracellular ice nuclei that can be prevented from growing during 
thawi ng only by rapid warming. On the other hand, very slow cooling may 
permit substantial net solute loading of cells and this could lead to 
osmotic lysis during rapid warming, since rapid thawing of ice will 
cause rapid dilution. Slow rewarming will enable the excess solute to 
leave the cells gradually. Slow warming, however, permits extensive 
recrystallisation of external ice with pronounced changes in the 
dimensions of the unfrozen liquid channels. When the melting of ice is 
complete, these cells and their surrounding medium still contain the 
initial concentration of cryoprotective agent and dilution must 
therefore be continued in order to return them to a physiological 
environment. As this is done, an osmotic gradient is again generated 
across the plasma membrane and this is relieved both by solute l oss and 
since it is a more rapid process, by the entry of water leading to cell 
swelling. If the cells are to survive the degree of swelling must be 
controlled and limited. This can be achieved by diluting the 
cryoprotective agent slowly or in a sequence of stepped 
may be 
decreases in 
concentration. Alternatively the cells placed in a 
cryoprotective agent free medium that contains a non-penetrating 
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substitute for the cryoprotective agent such as Mannitol which enables~ 
the cells to lose cryoprotective agent without a corresponding influx of 
water. 
Specific difficulties with freezing solid tissues 
The precise arrangement of many different types of cell and of 
extracellular structures that 
important additional difficulties 
comprise a whole organ introduces 
For example, the sheer size of an 
organ may render it impossible to achieve the desired rates of 
temperature change. The closed packing of the cells may invalidate 
extrapolation from dilute cell suspension. The presence of many 
different cell types might mean that no one cooling and warming 
procedure can satisfy them all. Also damage to extracellular 
structures from extracellular ice may be sufficient to destroy the organ 
even though the cells survive. There are a number of reports of 
attempts to cryopreserve whole organs using techniques derived from 
methods that were effective with single cell systems but these 
experiments have served only to emphasise the extreme difficulty of the 
enterprise (Pegg & Jacobson 1983). It very soon became clear that the 
introduction and removal of CPA had to be done very gently if injury was 
to be avoided and that even in the presence of one or two molar CPA 
moderate freezing produced severe damage. True cryopreservation 
(storage at -8d0 c or below) at least for several days has never been 
achieved. It seems that the major cause of freezing injury in whole 
organs is extracellular ice and that while cooling alone does cause 
damage, substantial progress will require techniques that will 
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completely prevent freezing or at least reduce the quantity of ice~ 
drastically. 
New approaches 
Two approaches are available. The first is to increase the 
concentration of CPA progressively during cooling relying upon the fall 
in CPA toxicity with decreasing temperature to make it possible to reach 
concentrations of CPA that will prevent freezing altogether. Attempts 
have been made to apply this approach experimentally so far without 
success, probably because of the technical difficulties of perfusion and 
diffusion at very low temperatures. The other approach is to employ 
conditions that favour vitrification rather than freezing. 
Vitrification is the amorphous solidification of solutions without the 
separation of ice crystals, and normally requires very high 
concentrations of appropriate solutes and rapid cooling. There are no 
studies in the literature on the cryopreservation of vascularised skin 
flaps. The method used for cryopreservation of the skin flaps which 
will be discussed later is mainly based on the experience of freezing 
skin. According to Berggren (1974) either a 1.4 mol glycerol or 1.4 
mol dimethylsulphoxide solution as a cryoprotectant is recommended in a 
balanced salt solution. The soaking time in dimethylsulphoxide should 
not exceed 1 hour whereas the skin should be exposed to glycerol for at 
least 2 hours. In both instances the soaking should be carried out at 
4° - 7°c. The cooling rate is not critical but it appears to be most 
satisfatory when it is slow. An acceptable range is 1°c per minute -
10°c per minute. Storage for long periods should be at temperatures 
less than -120°C for maximum storage times and the preservation of 
viability. 
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Storage at dry ice temperatures (-79°C) will give good results up to 5 
months but no reliable data are available for storage beyond this point 
at this temperature. 
Techniques of thawing 
Various techniques of thawing have been used but it is best achieved by 
immersing the frozen skin in a bath of sterile saline or Ringer's 
solution of 37°C.(Billingham & Medawar) Lehr 1964 found using 
Dimethylsulphoxide as a cryoprotectant agent for skin, that thawing had 
to be faster than 50°C per minute for maximum survival. Microwave 
thawing has also been studied but the use of domestic microwave ovens is 
to be avoided because of the difficulty of controlling energy absorption 
and the consequent risk of burning (Lehr 1971). Saline solution is not 
a balanced tissue solution and is therefore fairly damaging to tissues. 
Vascular damage 
A review of the literature on organ cryopreservation shows that a 
prominent feature of organs transplanted after freezing and thawing has 
been a rapid cessation of blood flow suggesting that vascular damage is 
an important factor in their functional failure.(Goodman et al 1977, 
Jacobson 1979, Jacobson et al 1984) It is assumed that this vascular 
damage is caused by the formation of ice in the lumina of the vessels. 
In the case of the investigated kidneys, it was particularly the 
glomerular capillaries. Jacobson et al found that both the glomerular 
and peritubular capillaries were distended which would not be expected 
once the perfusion pressure had been removed. Vascular distention was 
not observed either in immersion fixed or perfusion fixed unfrozen 
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organs. They also found that more ice was formed when the cooling rate 
was rapid than when it was slow. The shrunken and condensed vascular 
endothelium of their frozen kidneys was very similar to appearances that 
have been correlated with preservation of structure and function in 
other cells. While no confident conclusion can be drawn, the uniform 
appearance of the endothelium and only minor focal detachment from the 
basement membrane suggested that it had not been disrupted by cooling to 
-80°C at any of the rates used in their study. Jacobson et al found an 
optimal cooling and warming rate of 1°c per hour for kidneys. 
However, even in these transplants all the renal veins were found to be 
thrombosed when the grafts were removed and pronounced ischaemic damage 
was seen in the histological studies. They concluded that even a near 
normal and even pink colour of the kidneys was not a sufficient 
condition for post-transplant function. Goldman et al, investigating 
arterial interposition allografts showed that dimethylsulphoxide 
cryoprotected vein grafts showed evidence of aneurysm and thrombotic 
changes suggestive of early failure. They concluded that these grafts 
contained enough endothelium and cell debris to initiate thrombosis and 
resulting vascular injury. It has been assumed that the major site of 
the injury was the vascular endothelium and they suggested that the 
total stripping of vascular endothelium in conjunction with protection 
of organ function from cryoinjury would be an alternative approach to 
organ preservation. 
In conclusion one can say that cryoprotection of vascularised skin flaps 
has not been attempted yet, and it appears upon review of the literature 
that a vascular damage must be expected whatever techniques are used. 
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Comparing advantages and disadvantages of glycerol and 
dimethylsulphoxide it appeared that glycerol was less toxic, caused less 
vascular damage and required a slower thawing rate than 
dimethylsulphoxide. 
For the present study, slow cooling and rapid thawing was chosen as an 
appropriate procedure to use for the vascularized skin flaps using 
glycerol at a concentration of 1.6 mol. 
/ 
Kig_j_ Perfusion of rat hind 
limb with glycerol catheters 
are placed into femoral 
artery and vein 
/ 
Fig 2 The amputated, perfused 
and replanted leg 71 days 
postoperative. 
7 
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MATERIALS AND METHODS 
Long Evans outbred rats with an average weight of 300gm were used 
throughout the studies. 
Experiment 1 
- to show whether the cryprotective agent glycerol at the concentration 
of 1.6M would cause any localised tissue damage. 
Method: the hind limb of the rat was chosen. The limb was sub-totally 
amputated, leaving the femur and the sciatic nerve intact but dividing 
in a circular fashion the skin, subcutaneous tissue, vessels, and 
muscles. The bone was left intact to have a better post-operative 
stability and the sciatic nerve was left intact to leave sensitivity in 
the limb in order to prevent it from being chewed off. A catheter was 
inserted into the femoral artery and the limb was perfused in slowly 
increasing concentrations of glycerol, diluted in Ringer's solution up 
to a concentration of glycerol of 1.6M.(Fig.1) The glycerol was then 
washed out in the same procedure in slowly decreasing concentrations of 
glycerol again diluted with Ringer's solution. The femoral artery and 
vein were then anastomosed with 10/0 nylon interrupted sutures to regain 
a normal blood perfusion of the limb. 
Results: 
The first rat operated in this way died several hours after the 
operation for an unknown reason. The second rat died also after the 
replantation of the limb due to excessive blood loss. In the third rat, 
a thrombus formed at the site of the anastomosis and the rat had to be 
sacrificed three days post-operatively due to limb necrosis. In rat 
Fig 3a Histology skin 
Fig 3b Skeletal muscle 
Focal muscle atrophy 
and blood vessel 
proliferation 
Fig 3c New blood vessels 
Fig 3d Peripheral 
regenerating nerves 
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number four, the procedure was technically successful. The limb was 
well perfused and there was no significant post-operative oedema. 
Eight days post-operatively the fur of the operated leg became scarce 
and thin and on the eleventh post-operative day, the rat was found dead 
in the cage. No obvious reason could be found for this death. A fifth 
rat was done in the same way and in this case, a complete survival of 
the limb was noted. Three months post-operatively, the rat was walking 
on the replanted leg although it was not using it completely normally. 
(Fig. 2) Seven months after the operation the rat was walking normally 
on this leg. The rat was sacrificed, the leg amputated and sent for 
histological assessments. 
Histology findings: 
The general histological structure of the skin (Fig. 3a), subcutaneous 
tissue, and skeletal muscle (Fig 3b) was preserved. Focal 
proliferation of the connective fibrous tissue was seen between skeletal 
muscle fibres, which showed focal signs of atrophy or degeneration.(Fig 
3b & 3c) New blood vessel proliferation between muscular fibres and 
occasionally regenerating peripheral nerves were found.(Fig 3c & 3d) 
Experiment 2-
Aim: to develop a suitable groin flap for transplantation. 
A groin flap was designed+- 3x6 cm based on the superficial inferior 
epigastric artery and vein. The technique in the first three rats 
consisted of raising the flap incising the margin of the flap and 
dissecting it off the abdominal wall in the clear fasciral plane which 
is found just superficial to the muscle. Every bleeding point was 
cauterized, dissecting out the vascular pedicle, dividing the inferior 
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Fig 4 The vascular pedicle of 
the inguinal flap including the 
femoral and epigastric vessels 
Fig 5 A replanted inguinal 
flap 2 months postoperatively 
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epigastric artery and vein and anastomosing both vessels in an end-to-
side fashion to the femoral artery and vein (Diagram I). In all three 
cases, the anastomoses was patent post-operatively and there was good 
post-op perfusion of the flaps but all flaps became necrotic within four 
to thirteen days post-operatively. Because of the minimal size of the 
superficial inferior epigastric artery of which the outer diameter is+-
0,6 mm, this technique was abandoned and in all further experiments a 
segment of the femoral artery and vein were included into the vascular 
pedicle in order to achieve an easier and safer anastomosis. 
the femoral artery and vein were ligated.(Diagram 2 & Fig. 4) 
Methods 
Ten free groin flap replantations were done. 
Results 
Distally 
Five of these survived completely and those flaps which did not survive 
technical problems with the anastomosis, leading to occlusion, were the 
reasons for failure. The problems encountered occured mostly in the 
first flaps of the series; of the last six which were done, five 
survived. (Fig.5) The rats were sacrificed after 2 months. 
Experiments 3: 
Aim - to use a cryopreserved frozen flap in a transplant 
Method 
An inferior epigastric flap was dissected and raised using the same 
technique (Diagram 3) as described above including a segment of the 
femoral artery and vein. A small sized catheter with a diameter of 0,7 
mm was inserted into the femoral artery and the blood was then washed 
J ). FLA~ ~ CO ANO ~ARVE TEO 
Diagram 3 Demonstration of 
harvesting, cryoprotecting, 
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out with Ringer's solution adding continually glycerol of 1.6M until 
eventually only glycerol of 1.6M concentration was injected.(Fig.6) 
During the procedure, the flap was held outstretched with pins and 
cooled till +- 4°c (Fig 6). The flap was then put into a small 
container which was filled with glycerol of 1.6M concentration. This 
container was then placed into a deep freeze with a temperature of -
80°c. The cooling rate was+- 0,5°c per minute. The flaps were frozen 
for between 1 and 10 days. At the time of replantation, the recipient 
bed was prepared on the contra-lateral side by excising skin in the left 
abdominal area and demonstrating the femoral artery and vein. The flap 
was then thawed by immersing it into a water tank of 37°C resulting in a 
thawing time of 3-4 minutes. The flap was then washed out with slowly 
decreasing concentrations of glycerol and eventually pure Ringer's 
solution. The flap was then replanted applying end-to-end anastomosis 
to the femoral artery and vein. The rats were heparinised with 20 
units of heparin during both the period of raising the flap as well as 
replanting the flap. 
Results 
Seventeen flaps were raised for this procedure of which 14 were 
cryoprotected, frozen and replanted. Three 
because of insufficient perfusion with glycerol. 
flaps 
The 
were not frozen 
perfusion after 
harvesting the flap was a major problem and could not be solved 
satisfactorily in any of the cases. During the dissection of the 
vascular pedicle the vessels, specifically the superficial inferior 
epigastric artery, became so spastic that only a minimal amount of blood 
or none could pass this vascular segment. Various drugs have been used 
!ig_l Resin corrosion cast study 
R inguinal area without 
raising the skin flap. Note 
the thickness of the vessels. 
Fig 8 Another resin corrosion 
cast study after the flap has 
been raised. The diameter of 
the vessels is significantly 
smaller. 
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like Chlorpromazine and Lignocaine but only the latter in a 
concentration of 10% could solve this problem to some extent. With the 
external application of 10% Lignocaine the visible part of the vascular 
tree dilated significantly but it had no effect on the more distal 
branches within the flap. The most effective way, but by far not 
satisfactory to overcome this problem was to raise the flap and to 
dissect the vessels without transsecting them, tacking the flap back in 
place with a few sutures, covering the area with a moist swab, and then 
exposing it to a warm light source. A comparative resin corrosion cast 
study demonstrated the different diameter of the vessels when the resin 
was injected into the femoral artery without raising the flap and after 
the flap had been prepared in the way as described above.(Fig.7&8) 
Only in four flaps was there a good post-operative perfusion with blood. 
All these rats died in the early post-operative phase. Two of them 
probably died because of increased blood loss but the other two died for 
an unknown reason. In these two rats no significant amount of blood 
was found after their death neither in the dressings nor underneath the 
flap. 
There were no deaths in those rats where the retransplantation of the 
flap had been unsuccessful. Four flaps became necrotic at an earlier 
or later stage (Fig 9), two flaps were eaten by the rat itself. One 
flap had an immediate thrombosis of the vessels. In two flaps the 
vessels were accidentally injured during the procedure and in one case 
the rat died from an overdose of ether at the end of the procedure. 
Necrotic transplanted 
flap 
Fig 10 Vascular changes seen 
in electronmicroscopy 
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As there was no success in any of the frozen and replanted flaps a 
transmission electronmicroscopy study was used to show the extent of 
damage caused by the whole procedure. 
harvested in the usual manner. It 
A groin flap from a rat was 
was perfused in increasing 
concentrations with glycerol up to 1.6Mol, frozen for three weeks at -
soo, thawed in Ringer's solution at 37°c. The glycerol was washed out 
in decreasing concentrations with Ringer solution and the flap was then 
immediately prepared for the electronmicroscopy study. The flap was 
perfused with formalin and four samples were taken including a proximal 
part of the inferior epigastric artery, two sections from the skin and 
one from the subcutaneous tissue. The specimen consisting of a 
fragment of rat skin represented the findings: slightly edamatous rat 
skin covered by squamous epithelium which show mild focal vacuolar 
changes in endoplasmic reticulum. More advanced lesions were observed 
in capillaries of the skin. Some capillaries contained cellular debris 
in the luminal space and dilated endoplasmic reticulum of endothelial 
cells. Rarification and deformation of endothelial cytoplasmic 
processions and flattened endothelial cells were noted. Some 
capillaries contained relatively preserved or dying endothelial cells. 
Vacuolar degeneration was seen in pericytes, mild degenerative changes 
in the peripheral nerve myelin detected.(Fig 10) These changes confirm 
that the failure of the replanted frozen flaps are not due to a 
technical problem of the anastomosis but rather due to tissue damage in 
the flap itself . 
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DISCUSSION 
Many attempts of allotransplantation of composite tissues have been made 
with various methods of immunosuppression. By parabiosis and splenic 
tissue grafts from the donor Schwind induced immunological tolerance in 
non-inbred rats which later received a leg transplanted to their backs. 
In 75% of the animals this limb survived and grew. Lapchinsky has 
produced a functioning homotransplanted limb in a dog in which blood had 
been replaced six days after birth with that of an older dog later 
serving as the extremity donor. Goldwyn et al in 1966 in a study on 
canine limb homotransplantion transplanted hind limbs of dogs and used 
6-Mercaptopurine and azathioprine. With this treatment the limb 
rejection was definitely postponed in comparison to a non-treated 
control group but always occured and was qualitatively different from 
that observed in the untreated group. Poole et al used immunologic 
enhancement. In their study rats with successfully enhanced long term 
surviving kidney grafts subsequently underwent limb transplantation. 
These rats demonstrated significantly prolonged survival of the limb 
grafts compared with control rats that underwent limb transplantation 
only. Black et al felt that the administration of blood before 
transplantation would be the next logical choice in the attempt to 
enhance the survival of limb grafts. With this technique they could 
prolong the limb survival in average to five days to the control group. 
Salyer (1973) transplanted free vascularised skin flaps in which the 
recipients were pre-treated with goats' anti-rat lymphocyte serum and 
the donor animals were treated with whole body irradiation in order to 
destroy the passenger leucocytes. This resulted in a delay but not in 
a prevention of the subsequent graft versus host reaction. Doi in 1979 
51 
used non-specific inununosuppressive drugs (azathioprine, prednisolone and 
6-Mercaptopurine . in various concentrations and combinations) and 
achieved a delay of the rejection by an average of 7 days. Lance et 
al in 1971 used beagles as experimental animals and a similar regimen of 
inununosuppression. Their grafted limbs remained intact for 24, 30, 53, 
60, 71 and 112 days respectively and then the experiments had to be 
terminated for various reasons. A major breakthrough was achieved with 
the introduction of Cyclosporin A. Kim et al (1984), Black et al 
(1985), Press et al (1986), Hewitt et al (1983) used Cyclosporin A 
either alone or in combination with prednisolone and concentrations 
ranging between 5 and 20 mg per day. Indefinite survival was achieved 
by Black et al with 8mg per kg. a day Daniel et al transplanting limbs 
and free vascularised flaps in baboons needed very high Cyclosporin A 
levels for long-term survival of these transplants. Twenty mg per 
kilogram were injected twice daily to achieve serum levels between 800 
and 1000 microgram per millilitre. In the clinical situation a similar 
regimen would be prohibited by the known side-effects of Cyclosporin A. 
In this study a new method of reducing the antigenicity of free 
vascularised skin flaps was examined. Groin flaps from a rat were 
harvested, perfused with increasing concentrations of glycerol, frozen 
at -80°, before replantation thawed in 37° Ringer solution, the glycerol 
was washed out slowly decreasing the concentration and then 
transplanted. None of the 17 flaps transplanted this way survived any 
significant length of time. 
this failure. 
There are several factors contributing to 
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Firstly, the ischaemic time of the flap is considerably longer in the 
case of · perfusion and freezing in comparison to a simple immediate 
replantation. During the period of perfusion with increasing 
concentrations of glycerol, the flaps were cooled but on average the 
procedure of perfusion took approximately one hour. The flap then had 
still to be kept at a slightly below zero temperature to allow the 
glycerol to penetrate into the tissues for another two hours. Only then 
was the flap gradually frozen to -80°. During the thawing procedure 
again the flap was immersed in Ringers solution of 37° and although the 
flap was just thawed and not allowed to warm up to 37°, a warm ischaemic 
time could be expected as the more superficial structures would thaw 
earlier than the central structures. The cryoprotective agent then had 
to be slowly washed out and during the time of replantation it was 
technically impossible to continue the cooling of the flap, thus another 
warm ischaemic time was added averaging 90 minutes. 
Secondly, the procedure of perfusion of the flap with glycerol in itself 
causes damage to the intima of the vessels. Despite raising the flaps 
and exposure to a warm light source for three hours prior to injection, 
no means could be found by which the vessels could be dilated to the 
original size. As the perfusion following the transsection of the 
vessels had to be carried out through at least slightly constricted 
vessels, an increased pressure had to be applied in order to achieve a 
complete wash out of the blood and a good perfusion of the whole flap. 
This in itself may have caused damage to the intima, of the vessels 
which in addition to the trauma of freezing could be the reason of 
failure of the flaps to survive after the replantation. Harashina and 
Buncke did a study of washout solution for microvascular replantation_ 
and transplantation. In this study they compared the results of rat 
hind limbs replanted after thirty minutes at room temperature . In one 
group no irrigation was used; in a second group the limbs were perfused 
with heparinised saline for 30 minutes and in a third group perfused 
with a C3 (C3+Collins solution which is used for kidney perfusion, 
consists of: sodium 10, potassium 115, magnesium 30, sulphate 30, 
phosphate 50, chloride 15, bicarbonate 10, glucose 139, mMol/L, 
Osmolality 300 mosmol/kg) solution for 30 minutes with an average total 
ischaemic time of one and a half hours. In the second series, the 
limbs were replanted after 30 minutes at room temperature and 4 hours at 
40c. The groups were as described above, but under these circumstances 
the average total ischaemic time was five and a half hours. With the 
immediate replants in the first series, 92% of limbs that were not 
perfused, 50% of the group perfused with heparinised saline survived 
and 55% of the group perfused with C3 solution survived. The second 
series was identical to the first series except that the amputated limbs 
were subjected to four hours of anoxia. In the first group 73% 
survived, in the second group 47% survived and in the third group 33% 
' survived. In the discussi:on the authors comment that the hydrostatic 
pressure required to flush out the part itself damages the intima of the 
arteries causing subsequent thrombosis. In most instances, loss of a 
replant in their series was of gradual onset four to five days after 
replantation. This delayed loss might be attributed to disturbances in 
the micro-circulation due to the harmful effects of the washout 
solution. These disturbances seem to start with multiple areas of 
micronecrosis and then proceed to a total loss of the leg. They 
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discuss further that possible causes for the loss of the replants might 
be the pushing of micro-crystals or micro-organisms into the tissue by 
perfusion. If the solutions which these authors used caused such 
considerable damage, how much more damage can be expected if glycerol is 
added?(Marshall 1982)(See chapter on cryoprotectant agents) 
Thirdly cryopreserved vascularised whole organs have never been 
transplanted successfully and as such the vascularised skin flaps have 
to be regarded. Only tissues such as skin, cornea, parathyroid and 
pancreatic islets can be frozen and preserved. The reason why whole 
organs can not be cryopreserved yet is that each cell type has its own 
optimum conditions for preservation.(Mazur 1977) This means they 
require different cooling rates, warming rates different type and 
concentration of cryoprotectant which is specific for each cell or 
tissue. It appears that vessels are particularly susceptible to damage 
caused by the formation of ice in the lumina and particularly the 
capillaries (Jacobson et al 1984). This was confirmed in this 
investigation by the electronmicroscopic changes, where advanced lesions 
were observed in the capillaries of the skin. Some of the capillaries 
contained cellular debris in the luminar space and dilated endoplasmic 
reticulum of the endothelial cells. Also a rarification and deformation 
of endothelial cytoplasmic processes and flattened endothelial cells 
were noted. This confirms the findings of Jacobson et al in the case of 
investigated kidneys where the glomeruli and peritubular capillaries 
were distended which would not be expected once the perfusion pressure 
had been removed. This vascular distension was not observed either in 
immersion fixed or perfusion fixed unfrozen organs. 
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The fact that only four flaps were perfused sufficiently immediately 
after the transplantation could mean that the damage caused by the 
perfusion with Ringer solution and glycerol and the freezing, was so 
severe that the blood immediately clotted when it came into contact with 
the vessel walls. In those four cases where a sufficient perfusion was 
observed post-operatively, the rats died within the immediate post-
operative period. One reason for this could be that during the perfusion 
of the flap and the later wash out procedure, glycerol would diffuse 
into the extracellular space and would only be slowly resorbed from 
there after the transplantation of the flap was successful. It could 
well be that the glycerol in these amounts would have a toxic effect on 
the rats. Although hind limbs were perfused with glycerol in experiment 
1 and no systemic problems have been observed, it could be possible that 
the glycerol with its slow perfusion rate has been washed out before it 
could enter the interstitial space. Miehl et al report that with 
replanted dog legs severe acidosis and death can occur once circulation 
is re-established. This is due to the pyruvate and lactate radicals, 
and potassium ions which enter the system from the extracellular fluid. 
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CONCLUSIONS 
In this study I investigated the possibility of using freezing of 
tissues to diminish their immunogenicity. If this were successful, the 
transplantation of free vascularised skin flaps might be accomplished 
without the use of immunosuppressives which would be a great advantage. 
In this short study using perfusion of the flap with glycerol and 
subsequent slow freezing and thawing, it was observed that very severe 
damage was caused. Electronmicroscopy suggested that the principal 
region of damage was the vascular system and it is proposed that the use 
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